105 related articles for article (PubMed ID: 1892764)
1. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance.
Bush C; Price P; Norton J; Parkins CS; Bailey MJ; Boyd J; Jones CR; A'Hern RP; Horwich A
Br J Cancer; 1991 Aug; 64(2):357-60. PubMed ID: 1892764
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody.
Mazerolles C; Rishmann P; Chopin D; Popov Z; Malavaud B; Selves J; Neulat-Duga I; Bellot J; Delsol G
Histopathology; 1994 Dec; 25(6):563-8. PubMed ID: 7698733
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67.
Parkins CS; Bush C; Price P; Steel GG
Cell Prolif; 1991 Mar; 24(2):171-9. PubMed ID: 2009320
[TBL] [Abstract][Full Text] [Related]
4. Cell proliferation in serial biopsies through human malignant brain tumours: measurement using Ki67 antibody labelling.
Parkins CS; Darling JL; Gill SS; Revesz T; Thomas DG
Br J Neurosurg; 1991; 5(3):289-98. PubMed ID: 1892572
[TBL] [Abstract][Full Text] [Related]
5. Proliferation of invasive breast carcinomas and colorectal adenocarcinomas: an immunohistochemical in situ investigation with the monoclonal antibody Ki-67.
Horny HP; Horst HA
Zentralbl Allg Pathol; 1988; 134(6):547-54. PubMed ID: 3213288
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma.
Fontana D; Bellina M; Gubetta L; Fasolis G; Rolle L; Scoffone C; Porpiglia F; Colombo M; Tarabuzzi R; Leonardo E
J Urol; 1992 Oct; 148(4):1149-51. PubMed ID: 1404626
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Ki-67 monoclonal antibody as prognostic indicator for prostatic carcinoma.
McLoughlin J; Foster CS; Price P; Williams G; Abel PD
Br J Urol; 1993 Jul; 72(1):92-7. PubMed ID: 7511972
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
10. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
[TBL] [Abstract][Full Text] [Related]
11. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
[TBL] [Abstract][Full Text] [Related]
12. Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining.
Tsujihashi H; Nakanishi A; Matsuda H; Uejima S; Kurita T
J Urol; 1991 Apr; 145(4):846-9. PubMed ID: 2005717
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
14. Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67.
Okamura K; Miyake K; Koshikawa T; Asai J
J Urol; 1990 Oct; 144(4):875-8. PubMed ID: 2204729
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67).
Mulder AH; Van Hootegem JC; Sylvester R; ten Kate FJ; Kurth KH; Ooms EC; Van der Kwast TH
J Pathol; 1992 Jan; 166(1):37-43. PubMed ID: 1538273
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
17. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
Serio G
Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
[TBL] [Abstract][Full Text] [Related]
18. Expression of pS2 protein and its relation with the Ki-67 proliferative indices and tumor recurrence in superficial bladder carcinomas.
Sagol O; Yörükoglu K; Tuna B; Ozer E; Sis B; Güray M; Mungan U; Kirkali Z
Eur Urol; 2001 Aug; 40(2):163-8. PubMed ID: 11528193
[TBL] [Abstract][Full Text] [Related]
19. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value.
Zambelli S; Zanin A; Gaglio A; Zai G; Bosco E; Andrion A; Magnani C
Arch Ital Urol Androl; 1993 Dec; 65(6):665-70. PubMed ID: 8312949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
